Guardian Pharmacy Services, Inc. (NYSE:GRDN) Director Steven D. Cosler Acquires 7,000 Shares

Guardian Pharmacy Services, Inc. (NYSE:GRDN) Director Steven D. Cosler purchased 7,000 shares of Guardian Pharmacy Services stock in a transaction dated Tuesday, November 19th. The stock was bought at an average price of $21.22 per share, for a total transaction of $148,540.00. Following the completion of the purchase, the director now owns 17,713 shares in the company, valued at $375,869.86. This represents a 65.34 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Guardian Pharmacy Services Stock Down 1.3 %

GRDN opened at $21.28 on Thursday. Guardian Pharmacy Services, Inc. has a fifty-two week low of $14.16 and a fifty-two week high of $23.05.

Guardian Pharmacy Services (NYSE:GRDN) last issued its quarterly earnings data on Tuesday, November 12th. The company reported ($2.00) earnings per share for the quarter, missing the consensus estimate of $0.19 by ($2.19). The company had revenue of $314.39 million for the quarter, compared to the consensus estimate of $303.21 million. Equities analysts expect that Guardian Pharmacy Services, Inc. will post 0.86 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Guardian Pharmacy Services

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Virtu Financial LLC bought a new position in Guardian Pharmacy Services during the 3rd quarter worth approximately $279,000. Barclays PLC bought a new position in Guardian Pharmacy Services during the third quarter worth $311,000. Wellington Management Group LLP acquired a new position in Guardian Pharmacy Services in the third quarter valued at $8,400,000. Point72 DIFC Ltd bought a new stake in Guardian Pharmacy Services during the third quarter valued at $573,000. Finally, Maven Securities LTD acquired a new stake in Guardian Pharmacy Services during the 3rd quarter worth about $3,033,000.

Analyst Ratings Changes

A number of analysts have weighed in on GRDN shares. Truist Financial raised their target price on shares of Guardian Pharmacy Services from $22.00 to $24.00 and gave the company a “buy” rating in a research report on Friday, November 15th. Raymond James assumed coverage on Guardian Pharmacy Services in a report on Monday, October 21st. They set an “outperform” rating and a $21.00 price objective on the stock. Finally, Stephens started coverage on Guardian Pharmacy Services in a report on Tuesday, October 22nd. They issued an “overweight” rating and a $21.00 target price for the company.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.